Preparation and characterization of extracellular vesicles and their cutting-edge applications in regenerative medicine
Source abstract
Abstract
Extracellular vesicles (EVs) are biologically active nanoparticles secreted by cells, which have a variety of physiological functions, such as promoting cell proliferation, regulating immunity, anti-inflammation, and facilitating angiogenesis. However, the application of EVs is limited by defects such as low therapeutic efficiency, lack of targeting, and unstable therapeutic effects. In recent years, various engineering methods have been developed to enhance the function of EVs. In addition, the research on the isolation methods and mechanisms of EVs has also made significant progress. In this paper, we review the biogenesis, composition, and isolation techniques of EVs, summarize the potential therapeutic mechanisms of natural EVs as well as the engineering strategies for EV modification, and highlight the recent advances in the application of EVs in tissue regeneration. Finally, we discuss EVs' current problems and future perspectives in regenerative medicine.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Extracellular vesicles in disease · MicroRNA in disease regulation · Circular RNAs in diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. The biology, function, and biomedical applications of exosomes10.1126/science.aau6977 ↗
2. Communication by extracellular vesicles: where we are and where we need to go10.1016/j.cell.2016.01.043 ↗
3. Extracellular vesicle heterogeneity: subpopulations, isolation techniques, and diverse functions in cancer progression10.3389/fimmu.2018.00738 ↗
4. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes)10.1016/S0021-9258(18)48095-7 ↗
5. Extracellular vesicles: a bright star of nanomedicine10.1016/j.biomaterials.2020.120467 ↗
6. Mesenchymal stem cell exosomes: a two-edged sword in cancer therapy10.2147/IJN.S200036 ↗
7. Regenerative medicine, organ bioengineering and transplantation10.1002/bjs.11686 ↗
8. Stem cell-based therapy for human diseases10.1038/s41392-022-01134-4 ↗
9. Strange lesions after stem-cell therapy10.1038/465997a ↗
10. Extracellular vesicles for tissue repair and regeneration: evidence, challenges and opportunities10.1016/j.addr.2021.04.013 ↗
11. Mesenchymal stem cell-derived extracellular vesicles: toward cell-free therapeutic applications10.1038/mt.2015.44 ↗
12. Advances in extracellular vesicle functionalization strategies for tissue regeneration
13. Microvesicles in gliomas and medulloblastomas: an overview10.4236/jct.2014.52023 ↗
14. Functional extracellular vesicles for regenerative medicine10.1002/smll.202106569 ↗
15. Concise review: MSC-derived exosomes for cell-free therapy10.1002/stem.2575 ↗
16. Extracellular microvesicles as new industrial therapeutic frontiers10.1016/j.tibtech.2018.11.012 ↗
17. Bone-a-Petite: engineering exosomes towards bone, osteochondral, and cartilage repair10.1002/smll.202101741 ↗
18. Emerging role of the spleen in the pharmacokinetics of monoclonal antibodies
19. Delivering antisense oligonucleotides across the blood-brain barrier by tumor cell-derived small apoptotic bodies
20. Extracellular vesicles as bioactive nanotherapeutics: an emerging paradigm for regenerative medicine10.7150/thno.72812 ↗
21. Exosomes: extracellular organelles important in intercellular communication10.1016/j.jprot.2010.06.006 ↗
22. Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes10.3390/cells8040307 ↗
23. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication10.1038/s41556-018-0250-9 ↗
24. Exosomes: biogenesis, biologic function and clinical potential10.1186/s13578-019-0282-2 ↗
25. Cell-free exosome-laden scaffolds for tissue repair10.1039/D1NR01314A ↗
26. Therapeutic strategy of mesenchymal-stem-cell-derived extracellular vesicles as regenerative medicine10.3390/ijms23126480 ↗
27. Lipids in exosomes: current knowledge and the way forward10.1016/j.plipres.2017.03.001 ↗
28. Mesenchymal stromal/stem cell (MSC)-derived exosomes in clinical trials10.1186/s13287-023-03287-7 ↗
29. Role of MSC-derived small extracellular vesicles in tissue repair and regeneration
30. Mesenchymal Stem Cell (MSC)-derived extracellular vesicles: potential therapeutics as MSC trophic mediators in regenerative medicine10.1002/ar.24186 ↗
31. Clinical potential of mesenchymal stem cell-derived exosomes in bone regeneration10.3390/jcm12134385 ↗
32. Microparticles from kidney-derived mesenchymal stem cells act as carriers of proangiogenic signals and contribute to recovery from acute kidney injury10.1371/journal.pone.0087853 ↗
33. Mitovesicles are a novel population of extracellular vesicles of mitochondrial origin altered in down syndrome
34. exoRBase: a database of circRNA, lncRNA and mRNA in human blood exosomes10.1093/nar/gkx891 ↗
35. MicroRNA125b-mediated Hedgehog signaling influences liver regeneration by chorionic plate-derived mesenchymal stem cells10.1038/srep14135 ↗
36. Mesenchymal stem cells-derived extracellular vesicles, via miR-210, improve infarcted cardiac function by promotion of angiogenesis, Biochimica et biophysica acta10.1016/j.bbadis.2017.02.023 ↗
37. Enhanced cardioprotection by human endometrium mesenchymal stem cells driven by exosomal MicroRNA-2110.5966/sctm.2015-0386 ↗
38. An emerging focus on lipids in extracellular vesicles10.1016/j.addr.2020.03.002 ↗
39. Extracellular vesicles: emerging tools as therapeutic agent carriers10.1016/j.apsb.2022.05.002 ↗
40. Mesenchymal stem cell derived exosomes in cancer progression, metastasis and drug delivery: a comprehensive review10.7150/jca.25376 ↗
41. Extracellular vesicles, the cornerstone of next-generation cancer diagnosis?10.1016/j.semcancer.2021.05.011 ↗
42. Extracellular vesicles as biomarkers in liver diseases: a clinician's point of view10.1016/j.jhep.2020.07.014 ↗
43. Urine biopsy technologies: cancer and beyond10.7150/thno.44634 ↗
44. Malignant effusions and immunogenic tumour-derived exosomes10.1016/S0140-6736(02)09552-1 ↗
45. Can Extracellular Vesicles as Drug Delivery Systems Be a Game Changer in Cardiac Disease?10.1007/s11095-022-03463-z ↗
46. Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics10.7150/thno.41580 ↗
47. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research10.3402/jev.v2i0.20360 ↗
48. Optimized exosome isolation protocol for cell culture supernatant and human plasma10.3402/jev.v4.27031 ↗
49. The Yin and Yang of exosome isolation methods: conventional practice, microfluidics, and commercial kits10.1016/j.biotechadv.2021.107814 ↗
50. The role of microfluidics and 3D-bioprinting in the future of exosome therapy10.1016/j.tibtech.2023.05.006 ↗
51. Different EV enrichment methods suitable for clinical settings yield different subpopulations of urinary extracellular vesicles from human samples10.3402/jev.v5.29497 ↗
52. Technologies and standardization in research on extracellular vesicles10.1016/j.tibtech.2020.05.012 ↗
53. Isolation and characterization of exosomes for cancer research10.1186/s13045-020-00987-y ↗
54. Comprehensive isolation of extracellular vesicles and nanoparticles10.1038/s41596-023-00811-0 ↗
55. Isolation of mitochondria-derived mitovesicles and subpopulations of microvesicles and exosomes from brain tissues10.1038/s41596-022-00719-1 ↗
56. Purity and yield of melanoma exosomes are dependent on isolation method
57. Characterization of Urinary Exosomes Purified with Size Exclusion Chromatography and Ultracentrifugation10.1021/acs.jproteome.9b00693 ↗
58. Precipitation-based extracellular vesicle isolation from rat plasma co-precipitate vesicle-free microRNAs10.1080/20013078.2018.1555410 ↗
59. Single-step isolation of extracellular vesicles by size-exclusion chromatography10.3402/jev.v3.23430 ↗
60. Higher functionality of extracellular vesicles isolated using size-exclusion chromatography compared to ultracentrifugation10.1016/j.nano.2017.03.011 ↗
61. Effective isolation of exosomes with polyethylene glycol from cell culture supernatant for in-depth proteome profiling10.1039/C6AN00892E ↗
62. Towards microfluidic-based exosome isolation and detection for tumor therapy10.1016/j.nantod.2020.101066 ↗
63. Quantitative proteomic analysis of extracellular vesicle subgroups isolated by an optimized method combining polymer-based precipitation and size exclusion chromatography10.1002/jev2.12087 ↗
64. Precipitation with polyethylene glycol followed by washing and pelleting by ultracentrifugation enriches extracellular vesicles from tissue culture supernatants in small and large scales10.1080/20013078.2018.1528109 ↗
65. Reassessment of exosome composition10.1016/j.cell.2019.02.029 ↗
66. Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications10.1016/j.jconrel.2022.12.027 ↗
67. Mapping Subpopulations of cancer cell-derived extracellular vesicles and particles by nano-flow cytometry10.1021/acsnano.9b04480 ↗
68. Isolation of extracellular vesicles with combined enrichment methods10.1016/j.jchromb.2021.122604 ↗
69. Small extracellular vesicles isolation and separation: current techniques, pending questions and clinical applications10.7150/thno.74305 ↗
70. Isolation and profiling of circulating tumor-associated exosomes using extracellular vesicular lipid-protein binding affinity based microfluidic device10.1002/smll.201903600 ↗
71. Molecular and epigenetic basis of extracellular vesicles cell repair phenotypes in targeted organ-specific regeneration10.2174/1566524021666210210121905 ↗
72. In sickness and in health: the functional role of extracellular vesicles in physiology and pathology in vivo: part I: health and Normal physiology: part I: health and normal physiology10.1002/jev2.12151 ↗
73. Melatonin engineering M2 macrophage-derived exosomes mediate endoplasmic reticulum stress and immune reprogramming for periodontitis therapy10.1002/advs.202302029 ↗
74. Peripheral macrophage-derived exosomes promote repair after spinal cord injury by inducing local anti-inflammatory type microglial polarization via increasing autophagy10.7150/ijbs.54302 ↗
75. Therapeutic effects of human mesenchymal stem cell microvesicles in an ex vivo perfused human lung injured with severe E. coli pneumonia10.1136/thoraxjnl-2018-211576 ↗
76. Comprehensive molecular profiles of functionally effective MSC-derived extracellular vesicles in immunomodulation10.1016/j.ymthe.2020.04.020 ↗
77. Mesenchymal stromal cell-derived extracellular vesicles attenuate dendritic cell maturation and function10.3389/fimmu.2018.02538 ↗
78. Exosomes produced by adipose-derived stem cells inhibit schwann cells autophagy and promote the regeneration of the myelin sheath10.1016/j.biocel.2021.105921 ↗
79. Extracellular vesicles from NMN preconditioned mesenchymal stem cells ameliorated myocardial infarction via miR-210-3p promoted angiogenesis10.1007/s12015-022-10499-6 ↗
80. Extracellular vesicles from hair follicle-derived mesenchymal stromal cells: isolation, characterization and therapeutic potential for chronic wound healing10.1186/s13287-022-02824-0 ↗
81. Small extracellular vesicles derived from hypoxic mesenchymal stem cells promote vascularized bone regeneration through the miR-210-3p/EFNA3/PI3K pathway10.1016/j.actbio.2022.07.015 ↗
82. Induced pluripotent stem cell (iPSC)-derived extracellular vesicles are safer and more effective for cardiac repair than iPSCs10.1161/CIRCRESAHA.117.311769 ↗
83. Comparison of human embryonic stem cell-derived cardiomyocytes, cardiovascular progenitors, and bone marrow mononuclear cells for cardiac repair10.1016/j.stemcr.2015.09.011 ↗
84. Cardiovascular progenitor-derived extracellular vesicles recapitulate the beneficial effects of their parent cells in the treatment of chronic heart failure10.1016/j.healun.2016.01.013 ↗
85. Extracellular vesicles derived from hypoxia-preconditioned olfactory mucosa mesenchymal stem cells enhance angiogenesis via miR-61210.1186/s12951-021-01126-6 ↗
86. Bone marrow mesenchymal stem cell-derived exosomes promote rotator cuff tendon-bone healing by promoting angiogenesis and regulating M1 macrophages in rats10.1186/s13287-020-02005-x ↗
87. YAP/TAZ Orchestrate VEGF signaling during developmental angiogenesis10.1016/j.devcel.2017.08.002 ↗
88. Mesenchymal stem cell-derived small extracellular vesicles mitigate oxidative stress-induced senescence in endothelial cells via regulation of miR-146a/Src10.1038/s41392-021-00765-3 ↗
89. Removing the stumbling block of exosome applications in clinical and translational medicine: expand production and improve accuracy10.1186/s13287-023-03288-6 ↗
90. Preconditioning and engineering strategies for improving the efficacy of mesenchymal stem cell-derived exosomes in cell-free therapy10.1155/2022/1779346 ↗
91. Exosomes secreted from CXCR4 overexpressing mesenchymal stem cells promote cardioprotection via akt signaling pathway following myocardial infarction10.1155/2015/659890 ↗
92. Exosomes from hypoxia-treated human adipose-derived mesenchymal stem cells enhance angiogenesis through VEGF/VEGF-R10.1016/j.biocel.2019.01.017 ↗
93. Exosomes derived from atorvastatin-pretreated MSC accelerate diabetic wound repair by enhancing angiogenesis via AKT/eNOS pathway10.1186/s13287-020-01824-2 ↗
94. Exposure to blue light stimulates the proangiogenic capability of exosomes derived from human umbilical cord mesenchymal stem cells10.1186/s13287-019-1472-x ↗
95. Exosomes derived from miR-375-overexpressing human adipose mesenchymal stem cells promote bone regeneration10.1111/cpr.12669 ↗
96. Cylindrical microparticles composed of mesoporous silica nanoparticles for the targeted delivery of a small molecule and a macromolecular drug to the lungs: exemplified with curcumin and siRNA10.3390/pharmaceutics13060844 ↗
97. Mitochondria-rich extracellular vesicles rescue patient-specific cardiomyocytes from doxorubicin injury: insights into the SENECA trial10.1016/j.jaccao.2021.05.006 ↗
98. Pancreatic ductal cell-derived extracellular vesicles are effective drug carriers to enhance paclitaxel's efficacy in pancreatic cancer cells through clathrin-mediated endocytosis10.3390/ijms23094773 ↗
99. Embryonic stem cells-derived exosomes endowed with targeting properties as chemotherapeutics delivery vehicles for glioblastoma therapy10.1002/advs.201801899 ↗
100. Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment10.1016/j.biomaterials.2020.120546 ↗